JingChi Inc., a Bejing, China-based autonomous driving startup, completed a combined $52m Pre-Series A funding round.
EWatt Technology, a Wuhan, China-based developer of industrial-grade Unmanned Aerial Vehicles (UAVs) and implementing complete UAV solutions for industrial and security purposes, closed a $20M Series B funding round.
KPCB China veterans have launched China Creation Ventures, a new venture capital firm to identify and cultivate more early-stage Chinese startups.
Yi+, a Beijing, China-based startup which uses computer vision and artificial intelligence to provide intelligent media and marketing solutions, raised USD$15m in Series B funding.
XW Laboratories Inc., a Wuhan, China-based biopharmaceutical Research and Development (R&D) company focused on neurological disorders, closed a $17.5m Series B financing.
Warburg Pincus, a global private equity firm focused on growth investing, has acquired a 49% stake in Fortune SG Fund Management, a Shanghai, China-based asset management firm.
WuXi NextCODE, a Shanghai, China- Cambridge, Massachusetts- and Reykjavik, Iceland-based provider of a global platform for genomic data, completed $240M a Series B financing.
Global venture capital firm Eight Roads Ventures has launched a US$250M China Healthcare Fund.
Xing Bian Li (meaning New Convenience), a Shangai, CHina-based new retail company which integrates online and offline channels, along with offering both services and products, raised US$15m in angel funding.
OrbiMed, a NYC-based investment firm focused on the healthcare sector, closed its third Asia-focused private equity fund, with approximately $551m in capital commitments.
The People’s Bank of China declared ICOs illegal.
Meixin Global, a New York City based technology platform that lets asset managers access Chinese high-net-worth investors, closed over $5m in Series A financing round.
Zhaoyou, a Chinese business-to-business ecommerce platform for the petroleum industry, closed a $32m Series B financing.
CF PharmTech, Inc., a Suzhou, China-based specialty pharmaceutical company that develops and manufactures inhalation products, raised $65M in Series D financing.
Vipkid, a Beijing, China-based online English education company, raised $200m in series D financing.